Heart Data Often MIA From Cancer Trials

]]>(MedPage Today) -- Pivotal cancer trials have seriously under-reported cardiovascular disease (CVD) events, a study suggested.Only 62.4% of 189 phase II and III cancer therapy trials analyzed from 1998-2018 reported any incident CVD event at...